Eva U. Lorentzen

612 total citations
20 papers, 425 citations indexed

About

Eva U. Lorentzen is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Eva U. Lorentzen has authored 20 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Eva U. Lorentzen's work include Herpesvirus Infections and Treatments (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and COVID-19 Clinical Research Studies (4 papers). Eva U. Lorentzen is often cited by papers focused on Herpesvirus Infections and Treatments (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and COVID-19 Clinical Research Studies (4 papers). Eva U. Lorentzen collaborates with scholars based in Germany, Australia and Slovakia. Eva U. Lorentzen's co-authors include Joachim Kühn, Wali Hafezi, Bodo R. Eing, Alexandra Deters, Andrea Derksen, Andreas Hensel, Nicholas J. C. King, Marcus Müller, Ulrike Wieland and Barbara G. Klupp and has published in prestigious journals such as Journal of Virology, The FASEB Journal and Journal of Clinical Microbiology.

In The Last Decade

Eva U. Lorentzen

19 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva U. Lorentzen Germany 10 211 108 100 71 56 20 425
Marion Poenisch Germany 10 216 1.0× 100 0.9× 32 0.3× 88 1.2× 43 0.8× 11 404
Garry Lund Canada 12 232 1.1× 75 0.7× 66 0.7× 122 1.7× 27 0.5× 21 501
Erpeng Zhu China 15 115 0.5× 83 0.8× 105 1.1× 151 2.1× 73 1.3× 35 468
Laura Ruth Delgui Argentina 14 250 1.2× 76 0.7× 38 0.4× 130 1.8× 64 1.1× 21 451
Olivier Engler Switzerland 16 149 0.7× 227 2.1× 167 1.7× 165 2.3× 36 0.6× 39 721
Nicolás Corrales Chile 7 162 0.8× 33 0.3× 88 0.9× 57 0.8× 30 0.5× 11 300
Murat Ertürk United Kingdom 12 229 1.1× 27 0.3× 169 1.7× 71 1.0× 52 0.9× 21 411
Lara Grollo Australia 11 128 0.6× 85 0.8× 98 1.0× 117 1.6× 13 0.2× 18 380
Yiyu Lu China 12 164 0.8× 113 1.0× 95 0.9× 100 1.4× 18 0.3× 33 420
Jiangtao Xu China 11 103 0.5× 57 0.5× 38 0.4× 121 1.7× 58 1.0× 22 441

Countries citing papers authored by Eva U. Lorentzen

Since Specialization
Citations

This map shows the geographic impact of Eva U. Lorentzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva U. Lorentzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva U. Lorentzen more than expected).

Fields of papers citing papers by Eva U. Lorentzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva U. Lorentzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva U. Lorentzen. The network helps show where Eva U. Lorentzen may publish in the future.

Co-authorship network of co-authors of Eva U. Lorentzen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva U. Lorentzen. A scholar is included among the top collaborators of Eva U. Lorentzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva U. Lorentzen. Eva U. Lorentzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorentzen, Eva U., Alexander Mellmann, Georg Lenz, et al.. (2024). Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection. PLoS Pathogens. 20(10). e1012624–e1012624. 2 indexed citations
2.
Nowacki, Tobias M., et al.. (2024). SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients. Antibodies. 13(3). 78–78.
3.
4.
5.
Vollenberg, Richard, Phil‐Robin Tepasse, Eva U. Lorentzen, & Tobias M. Nowacki. (2022). Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study. Journal of Personalized Medicine. 12(5). 694–694. 6 indexed citations
6.
7.
Dugas, Martin, Uta Merle, Michaëla Fontenay, et al.. (2021). Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. Journal of Clinical Virology. 139. 104847–104847. 31 indexed citations
8.
Dugas, Martin, Richard Vollenberg, Eva U. Lorentzen, et al.. (2021). Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1). International Journal of Infectious Diseases. 105. 304–306. 36 indexed citations
9.
Zimmermann, Julian, Wali Hafezi, Eva U. Lorentzen, et al.. (2017). Enhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice. Journal of NeuroVirology. 23(3). 394–403. 24 indexed citations
10.
Klenner, Lars, Wali Hafezi, Björn E. Clausen, et al.. (2015). Cutaneous RANK–RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis. Journal of Investigative Dermatology. 135(11). 2676–2687. 8 indexed citations
11.
Hafezi, Wali, Eva U. Lorentzen, Bodo R. Eing, et al.. (2012). Entry of Herpes Simplex Virus Type 1 (HSV-1) into the Distal Axons of Trigeminal Neurons Favors the Onset of Nonproductive, Silent Infection. PLoS Pathogens. 8(5). e1002679–e1002679. 81 indexed citations
12.
Kühn, Joachim, Eva U. Lorentzen, Wali Hafezi, et al.. (2011). Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. Journal of Ethnopharmacology. 134(2). 468–474. 54 indexed citations
13.
Kühn, Joachim, Wali Hafezi, Andrea Derksen, et al.. (2010). Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Fitoterapia. 82(3). 408–413. 49 indexed citations
14.
Eing, Bodo R., Eva U. Lorentzen, Wali Hafezi, et al.. (2002). Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2. Journal of Clinical Microbiology. 40(2). 407–413. 26 indexed citations
15.
Hafezi, Wali, Bodo R. Eing, Eva U. Lorentzen, Solon Thanos, & Joachim Kühn. (2002). Reciprocal transmission of herpes simplex virus type 1 (HSV‐1) between corneal epithelium and trigeminal neurites in an embryonic chick organ culture. The FASEB Journal. 16(8). 878–880. 6 indexed citations
16.
Lorentzen, Eva U., Bodo R. Eing, Wali Hafezi, Roberto Manservigi, & Joachim Kühn. (2001). Replication-Competent Herpes simplex Virus Type 1 Mutant Expressing an Autofluorescent Glycoprotein H Fusion Protein. Intervirology. 44(4). 232–242. 7 indexed citations
17.
Kühn, Joachim, Thomas Wendland, Hans J. Eggers, et al.. (1995). Quantitation of human cytomegalovirus genomes in the brain of AIDS patients. Journal of Medical Virology. 47(1). 70–82. 24 indexed citations
18.
Kehm, Roland, Eva U. Lorentzen, Angela Rösen‐Wolff, & Gholamreza Darai. (1994). In vitro expression of UL56 gene of herpes simplex virus type 1; detection of UL56 gene product in infected cells and in virions. Virus Research. 33(1). 55–66. 7 indexed citations
19.
Lorentzen, Eva U., et al.. (1991). In vitro cleavage of HIV-1 vif RNA by a synthetic ribozyme. Virus Genes. 5(1). 17–23. 11 indexed citations
20.
Kühn, Joachim, et al.. (1990). Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. Journal of Virology. 64(6). 2491–2497. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion Poenisch Breakdown of academic impact, for papers by Garry Lund Breakdown of academic impact, for papers by Erpeng Zhu Breakdown of academic impact, for papers by Laura Ruth Delgui Breakdown of academic impact, for papers by Olivier Engler Breakdown of academic impact, for papers by Nicolás Corrales Breakdown of academic impact, for papers by Murat Ertürk Breakdown of academic impact, for papers by Lara Grollo Breakdown of academic impact, for papers by Yiyu Lu Breakdown of academic impact, for papers by Jiangtao Xu
Rankless by CCL
2026